Traders expect the Federal Reserve to pause future rate rises, Bristol-Myers Squibb's $90bn takeover of Celgene signals a big year for pharma M&A and agricultural researchers discover a genetic breakthrough in crop growth. Then, why EU officials are looking to toughen scrutiny of potential security risks with Chinese technology companies.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av FT News Briefing
Visa alla avsnitt av FT News BriefingFT News Briefing med Financial Times finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
